Gsa Capital Partners LLP Johnson & Johnson Transaction History

Gsa Capital Partners LLP

$1.2 Billion
Q3 2025

A detailed history of Gsa Capital Partners LLP transactions in Johnson & Johnson stock. As of the latest transaction made, Gsa Capital Partners LLP holds 5,142 shares of JNJ stock, worth $1.03 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,142

Previous 19,579 73.74%

Holding current value

$1.03 Million

Previous $2.99 Million 68.14%

% of portfolio

0.08%

Previous 0.21%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$155.17 - $185.42 $2.24 Million - $2.68 Million	-14,437 Reduced 73.74%	5,142 $953,000
Q2 2025 Jul 22, 2025	BUY	$146.36 - $159.82 $2.38 Million - $2.6 Million	16,261 Added 490.08%	19,579 $2.99 Million
Q1 2025 May 08, 2025	SELL	$142.06 - $167.7 $133,678 - $157,805	-941 Reduced 22.09%	3,318 $550,000
Q4 2024 Feb 07, 2025	BUY	$143.34 - $165.86 $610,485 - $706,397	4,259 New	4,259 $616,000
Q2 2024 Aug 15, 2024	BUY	$144.38 - $157.78 $3.28 Million - $3.58 Million	22,697 New	22,697 $3.32 Million

Q4 2023 Feb 16, 2024	BUY	$145.6 - $158.88 $655,928 - $715,754	4,505 Added 160.72%	7,308 $1.15 Million
Q3 2023 Nov 15, 2023	BUY	$155.75 - $174.48 $436,567 - $489,067	2,803 New	2,803 $436,000
Q2 2022 Aug 09, 2022	SELL	$168.19 - $186.01 $216,628 - $239,580	-1,288 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$158.14 - $179.59 $203,684 - $231,311	1,288 New	1,288 $228,000
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $699,456 - $777,284	-4,331 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$159.48 - $171.07 $690,707 - $740,904	4,331 New	4,331 $713,000
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $481,362 - $581,140	-3,737 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $145,259 - $201,264	1,307 Added 53.79%	3,737 $490,000
Q4 2019 Feb 12, 2020	SELL	$127.5 - $146.44 $845,962 - $971,629	-6,635 Reduced 73.19%	2,430 $354,000
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $1.01 Million - $1.13 Million	-7,930 Reduced 46.66%	9,065 $1.17 Million
Q2 2019 Aug 06, 2019	BUY	$131.15 - $144.24 $618,109 - $679,803	4,713 Added 38.37%	16,995 $2.37 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $1.51 Million - $1.68 Million	-12,017 Reduced 49.45%	12,282 $1.72 Million
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $686,552 - $826,277	5,589 Added 29.87%	24,299 $3.14 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $1.7 Million - $2 Million	13,990 Added 296.4%	18,710 $2.59 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $75,102 - $82,877	629 Added 15.38%	4,720 $573,000
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $3.71 Million - $4.4 Million	-29,687 Reduced 87.89%	4,091 $524,000
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $723,022 - $791,346	5,510 Added 19.49%	33,778 $4.72 Million
Q3 2017 Nov 20, 2017	BUY	$129.47 - $135.38 $3.66 Million - $3.83 Million	28,268	28,268 $3.68 Million

Others Institutions Holding JNJ

# of Institutions

4,908

Shares Held

1.74B

Call Options Held

19.8M

Put Options Held

16.7M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $522B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Johnson & Johnson Transaction History